Healthcare · Pharmaceutical expenditure

Pharmaceutical expenditure in Botswana in 2026

Pharmaceutical expenditure in Botswana stands at 1 % GDP of GDP in 2026, a modest figure given the rising burden of non-communicable diseases. A significant portion of medicines is imported from South Africa and India, with the state's antiretroviral procurement program remaining a key cost driver. The country holds the 114th position among 197 nations.

Data for 2026 · unit: % GDP
Position

Botswana world ranking

#114 / 197

Country position on the scale from last to first place for this indicator.

BW
#114
#197#1
Trend

Change over time

Change in indicator over the available period.

1.00
1990
1.20
2000
1.40
2010
1.60
2020
1.00
2026

Values — % GDP

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical expenditure in Botswana — how much?
Based on 2026 data — 1 % GDP. This is rank #114 out of 197 countries.
What is Botswana's rank by Pharmaceutical expenditure?
Botswana ranks #114 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Botswana?
Over the available period the indicator changed from 1 to 1 % GDP.